All Articles

NeuroPace reports strong Q2 growth and raises 2026 guidance, driven by its RNS system. A new AI tool and key clinical data signal a deeper push into personalized medicine.

With FDA clearance for its AI burn scanner, Spectral AI faces its next test: conquering the market. Can it turn government contracts into commercial success?

A sharp revenue drop and net loss for IZEA masks a major strategic pivot. With $46M in cash, the company is betting its future on enterprise clients.

AGT Food and Ingredients' Q2 results signal a successful shift to higher-margin foods, with its packaged foods segment surging despite global headwinds.

A pivotal ATF ruling reclassifies the BolaWrap as a restraint tool, not a weapon. This opens a vast private market, but as the tool expands beyond police, new questions of oversight arise.

While the dry bulk market is strong, Pangaea's Q2 earnings reveal a model where specialized fleets and integrated logistics deliver superior, market-beating margins.

Kodiak Sciences launches a pivotal trial for a new drug aiming to best current treatments for diabetic eye disease. Is this the future of vision care?

RBI will use cash on hand to repurchase 2.8M units from 3G Capital, a move set to boost EPS and signal a strategic recalibration by its largest shareholder.

Matthews International appoints Michael Whitehead, a tech growth leader from Lincoln Electric, to navigate a portfolio transformation and reverse recent financial turbulence.

A routine dividend from Genuine Parts Company offers a rare look into the financial health of the vast, physical network that keeps our world moving.

A Singapore data center operator is merging with a Silicon Valley AI startup, creating a new U.S.-based contender in the booming AI inference market.

abrdn's latest CEF distributions promise steady income, but a closer look reveals a complex web of 'return of capital' and managed policies. Here's what investors need to know.

Summit Midstream posts strong Q2 earnings, but a closer look reveals a strategic pivot, funding a Williston revival while grappling with declining assets.

With a second secret, multi-billion-dollar deal, Pure Storage is outmaneuvering giants to power the AI era. It's a quiet war for the data center's soul.

As VolitionRx readies its Q2 update, investors and scientists look for proof that its pioneering epigenetic tests can translate into commercial success.

National Health Investors' Q2 results reveal a bold strategy: selling a $560M legacy portfolio to fuel an aggressive expansion into private-pay senior housing.

Radiant Logistics has refinanced its debt, securing a flexible $200M credit line with better terms, extending its financial runway and fueling its M&A ambitions.

MySize Inc. is consolidating its shares to stay on Nasdaq. We go beyond the press release to analyze if this financial maneuver is a path to stability or a warning sign.

A new campaign asks Oregonians to recycle their old electronics. But behind the ads is a systemic overhaul of who pays for our digital debris.

The new-age power derivatives exchange gets a regulatory green light to bring in traditional brokers, a move set to deepen liquidity and reshape energy hedging.